ConductScience.org, home

Paper25367883

Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.

Wang W and 3 others. Mol Neurobiol, 2015. Cited by 119 papers, by iCite.

Cite this record

ConductScience Library. Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers. Papers, record 25367883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25367883

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.
PubMed
Journal
Mol Neurobiol
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
4.77
iCite
Revised in PubMed
2022-04-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang WWei
2Li MMingchang
3Chen QQianxue
4Wang JJian

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain IschemiaMajor topic
Cerebral HemorrhageMajor topic
Fibrinolytic AgentsMajor topic
Thrombolytic TherapyMajor topic
Tissue Plasminogen ActivatorMajor topic
Animals
Astrocytes
Biomarkers
Blood-Brain Barrier
Carboxypeptidase B2
Chemotaxis, Leukocyte
Disease Models, Animal
Early Diagnosis
Endothelium, Vascular
F2-Isoprostanes
Humans
Macrophage Activation
Matrix Metalloproteinases
Mice
Microglia
Models, Neurological
Nerve Tissue Proteins
Neuroimaging
Oxidative Stress
Plasminogen Activator Inhibitor 1

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K01AG031926NIA NIH HHSUnited StatesK01AG031926PubMed and NIHNIH RePORTER
R01AT007317NCCIH NIH HHSUnited StatesR01AT007317PubMed and NIHNIH RePORTER
R01NS078026NINDS NIH HHSUnited StatesR01NS078026PubMed and NIHNIH RePORTER
R01 AT007317NCCIH NIH HHSUnited StatesR01AT007317PubMed and NIHNIH RePORTER
R01 NS078026NINDS NIH HHSUnited StatesR01NS078026PubMed and NIHNIH RePORTER
K01 AG031926NIA NIH HHSUnited StatesK01AG031926PubMed and NIHNIH RePORTER

Download CSV of grants

References99

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121030711Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial.Stroke2010https://conductscience.org/library/papers/21030711PubMed
215073398Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia.Stroke2004https://conductscience.org/library/papers/15073398PubMed
310894177Evolution of brain infarction after transient focal cerebral ischemia in mice.J Cereb Blood Flow Metab2000https://conductscience.org/library/papers/10894177PubMed
425187778Ischemia-reperfusion injury in stroke.Interv Neurol2013https://conductscience.org/library/papers/25187778PubMed
524619394Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke.Stroke2014https://conductscience.org/library/papers/24619394PubMed
618323498MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.Stroke2008https://conductscience.org/library/papers/18323498PubMed
717673718Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.Stroke2007https://conductscience.org/library/papers/17673718PubMed
821597015Microbleeds are associated with subsequent hemorrhagic and ischemic stroke in healthy elderly individuals.Stroke2011https://conductscience.org/library/papers/21597015PubMed
918927459Extension of the thrombolytic time window with minocycline in experimental stroke.Stroke2008https://conductscience.org/library/papers/18927459PubMed
1016497981Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.Stroke2006https://conductscience.org/library/papers/16497981PubMed
1123565108Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.Front Neurol2013https://conductscience.org/library/papers/23565108PubMed
1223587928Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging features.Magn Reson Imaging2013https://conductscience.org/library/papers/23587928PubMed
1315541709Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF.Ageing Res Rev2004https://conductscience.org/library/papers/15541709PubMed
1425016287SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice.Brain Res2014https://conductscience.org/library/papers/25016287PubMed
1522354151Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation.J Cereb Blood Flow Metab2012https://conductscience.org/library/papers/22354151PubMed
1621689752Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia.Neurobiol Dis2011https://conductscience.org/library/papers/21689752PubMed
178476577Endothelial-leukocyte adhesion molecules.Annu Rev Immunol1993https://conductscience.org/library/papers/8476577PubMed
1822116809Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.Stroke2012https://conductscience.org/library/papers/22116809PubMed
197477192Tissue plasminogen activator for acute ischemic stroke.N Engl J Med1995https://conductscience.org/library/papers/7477192PubMed
2023881959Cilostazol ameliorates warfarin-induced hemorrhagic transformation after cerebral ischemia in mice.Stroke2013https://conductscience.org/library/papers/23881959PubMed

See all 99 referencesDownload CSV of references

Cited by86

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
42589214Alpha2-Antiplasmin Limits Fibrinolysis by Tenecteplase and Enhances Brain Injury After Reperfusion in Ischemic Stroke.Int J Mol Sci2026https://conductscience.org/library/papers/42589214PubMed
42512479Baseline ASPECTS, Fibrinogen Level, and Platelet Count for Predicting Hemorrhagic Transformation After Mechanical Thrombectomy in Acute Ischemic Stroke.Brain Sci2026https://conductscience.org/library/papers/42512479PubMed
42161231Activation of sarco/endoplasmic reticulum Ca²⁺-ATPase 2 (SERCA2) reduces brain injury and improves cognitive function following ischemic stroke.Biomed Pharmacother2026https://conductscience.org/library/papers/42161231PubMed
42066623PEBP1 inhibition as a therapeutic target for neurological recovery in ischemic stroke.Neurotherapeutics2026https://conductscience.org/library/papers/42066623PubMed
41549168Impact of Asymptomatic Intracranial Hemorrhage on Outcome After Endovascular Stroke Treatment.Ann Clin Transl Neurol2026https://conductscience.org/library/papers/41549168PubMed
41301476High-Resolution Spatiotemporal Mapping of Cerebral Metabolism During Middle-Cerebral-Artery Occlusion/Reperfusion Progression: Preliminary Insights.Biomolecules2025https://conductscience.org/library/papers/41301476PubMed
40771969The role of ASPECTS score, atrial fibrillation, and revascularization therapy in predicting hemorrhagic transformation of ischemic stroke: results from a prospective cohort study.Front Neurol2025https://conductscience.org/library/papers/40771969PubMed
40637138Acupuncture Alleviates Blood-Brain Barrier Damage After Delayed rtPA Thrombolysis for Acute Ischemic Stroke by Regulating Ferroptosis.Brain Behav2025https://conductscience.org/library/papers/40637138PubMed
40509244Regulation of Blood-Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer's Disease and Brain Tumors.Molecules2025https://conductscience.org/library/papers/40509244PubMed
40476578Matrix metalloproteinase‑9 in hemorrhagic transformation after acute ischemic stroke (Review).Mol Med Rep2025https://conductscience.org/library/papers/40476578PubMed
40376152Predictive value of the fibrinogen-to-albumin ratio for hemorrhagic transformation following intravenous thrombolysis in ischemic stroke: a retrospective propensity score-matched analysis.Front Neurol2025https://conductscience.org/library/papers/40376152PubMed
40327074Comprehensive and high-coverage glycerophospholipidomic analysis based on iterative quadrupole time-of-flight mass spectrometry and its application in cerebral ischemia-reperfusion injury.Anal Bioanal Chem2025https://conductscience.org/library/papers/40327074PubMed
40116141Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Induced Brain Hemorrhagic Transformation After Ischemic Stroke.CNS Neurosci Ther2025https://conductscience.org/library/papers/40116141PubMed
39531192Alpha‑Asarone Ameliorates Neuronal Injury After Ischemic Stroke and Hemorrhagic Transformation by Attenuating Blood-Brain Barrier Destruction, Promoting Neurogenesis, and Inhibiting Neuroinflammation.Mol Neurobiol2025https://conductscience.org/library/papers/39531192PubMed
39424403Enhancing Blood-Brain Barrier Integrity in Patients With Acute Ischemic Stroke Via Normobaric Hyperoxia.J Am Heart Assoc2024https://conductscience.org/library/papers/39424403PubMed
38682172Dexmedetomidine alleviates blood-brain barrier disruption in rats after cerebral ischemia-reperfusion by suppressing JNK and p38 MAPK signaling.Korean J Physiol Pharmacol2024https://conductscience.org/library/papers/38682172PubMed
38681090Innovations in Breaking Barriers: Liposomes as Near-Perfect Drug Carriers in Ischemic Stroke Therapy.Int J Nanomedicine2024https://conductscience.org/library/papers/38681090PubMed
38312551The combination model of serum occludin and clinical risk factors improved the efficacy for predicting hemorrhagic transformation in stroke patients with recanalization.Heliyon2024https://conductscience.org/library/papers/38312551PubMed
38161346The early predictive value of platelet-to-lymphocyte ratio to hemorrhagic transformation of young acute ischemic stroke.Asian Biomed (Res Rev News)2023https://conductscience.org/library/papers/38161346PubMed
38132972Hemorrhagic Coagulation Disorders and Ischemic Stroke: How to Reconcile Both?Neurol Int2023https://conductscience.org/library/papers/38132972PubMed

See all 86 cited byDownload CSV of cited by

Genes20

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCL26347PubTator's text mininghttps://conductscience.org/library/genes/6347NCBI Gene
CETN11068PubTator's text mininghttps://conductscience.org/library/genes/1068NCBI Gene
CLDN19076PubTator's text mininghttps://conductscience.org/library/genes/9076NCBI Gene
CLDN57122PubTator's text mininghttps://conductscience.org/library/genes/7122NCBI Gene
CPB21361PubTator's text mininghttps://conductscience.org/library/genes/1361NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
GRIN12902PubTator's text mininghttps://conductscience.org/library/genes/2902NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
MMP104319PubTator's text mininghttps://conductscience.org/library/genes/4319NCBI Gene
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
MMP34314PubTator's text mininghttps://conductscience.org/library/genes/4314NCBI Gene
MMP94318PubTator's text mininghttps://conductscience.org/library/genes/4318NCBI Gene
OCLN100506658PubTator's text mininghttps://conductscience.org/library/genes/100506658NCBI Gene
PLAT5327PubTator's text mininghttps://conductscience.org/library/genes/5327NCBI Gene
PLG5340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
S100B6285PubTator's text mininghttps://conductscience.org/library/genes/6285NCBI Gene
SERPINE15054PubTator's text mininghttps://conductscience.org/library/genes/5054NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25367883

GET https://conductscience.org/api/papers/v1/25367883/references?page=2